[Latin Name] Cucurbita pepo

[Plant Source]from China

[Specifications] 10:1 20:1

[Appearance] Brown yellow fine powder

Plant Part Used:Seed

[Particle size] 80 Mesh

[Loss on drying] ≤5.0%

[Heavy Metal] ≤10PPM

[Storage] Store in cool & dry area, keep away from the direct light and heat.

[Shelf life] 24 Months

[Package] Packed in paper-drums and two plastic-bags inside.

[Net weight] 25kgs/drum

Introduction

Pumpkin seed is used medicinally to help improve bowel function by ridding the intestinal tract of parasites and worms.

As raw material of drugs for eliminating insecticide, swelling, andpertussis, pumpkin seed extract is widely used in pharmaceutical industry;

As product of treating malnutrition and prostate, pumpkin seed extract is widely used in health industry.

FUNCTION:

1.Pumpkin seed extract can help to prevent the prostate disease.

2.Pumpkin seed extract has the function of treating whooping cough and children with sorethroat.

3.Pumpkin is also a natural source of magnesium, phosphorus, selenium, zinc, vitamin A, and vitamin C.

4.The cushaw extract is also a laxative, which can help to moisture the skin, is indeed a good beauty food for women.

5.Pumpkin seed is used medicinally to help improve bowel function by ridding the intestinal tract of parasites and worms.

6.The cushaw seed extract have much acid , this acid can relax the rest angina, and have a function to low the high blood liquid

What Our Customer say about after taking Hotton Candy.

medskl.com is a global, free open access medical education (FOAMEd) project covering the fundamentals of clinical medicine with animations, lectures and concise summaries. medskl.com is working with over 170 award-winning medical school professors to provide content in 200+ clinical presentations for use in the classroom and for physician CME.

Primary Care – Infant and Child Immunization
Whiteboard Animation Transcript
with David Scheifele, MD

https://medskl.com/Module/Index/infant-and-child-immunization

Modern vaccines are safe and impressively effective, potentially eliminating circulation of most target infections. Immunization allows for protection against a broad range of infections.

During pregnancy, transplacental passage of maternal IgG antibodies allows for passive protection in the first 6 months of life. This, however, decays rapidly, with little remaining beyond 6 months of age. Thus, early infancy is the ideal time to begin immunization so that active immunity can replace waning passive protection without a period of vulnerability in between.

To achieve this goal, infants typically require several initial vaccine doses spaced about 8 weeks apart, known as the primary series. It ensures that their immature immune system responds adequately. Adherence to the schedule minimizes infection risks. Depending on the vaccine, a booster dose may be required in the second year of life to reinforce the antibody response and extend protection throughout early childhood; additional booster doses may be needed at 4-6 years and in adolescence to renew and extend protection.

Immunization schedules vary to some extent across regions and you should become familiar with the schedule used in your region of practice.

As clinicians, you will often get asked about the safety profiles of childhood vaccines. In general, almost all of these vaccines are well tolerated and cause very mild side effects, such as injection site pain or transient fever. The tangible risks are febrile seizures and hypotonic (fainting) spells, which both have low risk rates and benign outcomes.

This table lists some of the rare complications associated with vaccines.

MMR meningitis is mainly attributable to the mumps component and differs among products, being very unlikely with the vaccines used in Canada. Measles encephalitis is a great rarity, seen in a few immunocompromised vaccinees.

Lastly, presence of certain health conditions will alter immunization recommendations. Children at high risk for invasive pneumococcal infection should get 3 primary doses of the PCV13 vaccine (instead of 2) and should also receive the 23-valent pneumococcal polysaccharide vaccine after age 2, which is not part of the routine schedule. Immunocompromised children should not receive live attenuated vaccines.